Takeda (NYSE: TAK) director Paulus Stoffels receives share and tax-linked awards

Rhea-AI Filing Summary

Takeda Pharmaceutical director Paulus Stoffels reported an equity compensation grant. He acquired 3,800 Ordinary Shares on a grant or award basis, bringing his directly held Ordinary Shares to 3,800.

He was also granted 1,307 Tax Obligation Awards, each economically equivalent to one Ordinary Share. The related restricted stock units vest on June 1, 2029 and will convert into Ordinary Shares, which are then deliverable as American Depositary Shares. The Tax Obligation Awards are structured to pay cash at vest, primarily to cover tax obligations based on the then-current market price.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Stoffels Paulus

Role null

Type	Security	Shares	Price	Value
Grant/Award	Tax Obligation Award	1,307	$0.00	--
Grant/Award	Ordinary Shares	3,800	$0.00	--

Holdings After Transaction: Tax Obligation Award — 1,307 shares (Direct, null); Ordinary Shares — 3,800 shares (Direct, null)

Footnotes (1)

1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Key Figures

Ordinary Shares granted: 3,800 shares Ordinary Shares held after grant: 3,800 shares Tax Obligation Awards granted: 1,307 awards +1 more

4 metrics

Ordinary Shares granted 3,800 shares Grant or award acquisition on July 1, 2026; holdings after transaction

Ordinary Shares held after grant 3,800 shares Total directly held by Paulus Stoffels following the transaction

Tax Obligation Awards granted 1,307 awards Derivative-type awards economically equivalent to one Ordinary Share each

RSU vesting date June 1, 2029 Restricted stock units convert to Ordinary Shares, then American Depositary Shares

Key Terms

restricted stock units (RSU), American Depositary Shares, Tax Obligation Award

3 terms

restricted stock units (RSU) financial

"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share"

American Depositary Shares financial

"Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Tax Obligation Award financial

"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 06:11 PM Accepted by SEC EDGAR 07/06/2026 - 06:11 PM Learn about SEC filing dates

FAQ

What did Paulus Stoffels report in this Takeda (TAK) Form 4 filing?

Paulus Stoffels reported receiving equity compensation from Takeda, including 3,800 Ordinary Shares and 1,307 Tax Obligation Awards. These awards are part of his director compensation and include future vesting and tax-related features tied to Takeda’s share price.

How many Takeda (TAK) shares does Paulus Stoffels hold after this grant?

After the grant, Paulus Stoffels directly holds 3,800 Ordinary Shares of Takeda. In addition, he has 1,307 Tax Obligation Awards tied economically to Ordinary Shares, which are designed to settle in cash mainly to cover future tax obligations at vesting.

What are the key terms of the restricted stock units granted to Paulus Stoffels at Takeda (TAK)?

The grant includes restricted stock units where each unit represents a contingent right to receive one Ordinary Share. These RSUs vest on June 1, 2029 and will be converted into an equivalent number of American Depositary Shares upon vesting, providing long-term equity-based compensation.

What is a Tax Obligation Award in this Takeda (TAK) Form 4?

Each Tax Obligation Award is economically equivalent to one Ordinary Share and will vest into a cash payment. The payment is primarily intended to cover tax obligations and is based on the then-current market price of Takeda’s Ordinary Shares at the time of vesting.

Does this Takeda (TAK) Form 4 show an open-market stock purchase or sale by Paulus Stoffels?

The Form 4 shows grant or award acquisitions, not open-market trades. The 3,800 Ordinary Shares and 1,307 Tax Obligation Awards were received as compensation at a reported price of zero per share, reflecting stock-based awards rather than discretionary market buying or selling.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stoffels Paulus

(Last) (First) (Middle)

C/O TAKEDA PHARMACEUTICAL COMPANY

1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU

(Street)

TOKYO 103-8668

(City) (State) (Zip)

JAPAN

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/01/2026		A(1)		3,800	A	$0	3,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Tax Obligation Award	(2)	07/01/2026		A		1,307		06/01/2029	06/01/2029	Ordinary Shares	1,307	$0	1,307	D

Explanation of Responses:

1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.

2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

	/s/ /s/ Samuel Ntonme, by power of attorney, for Paul Stoffels	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)